New Delhi: The vaccine is effective on the new B.1.617.2 variant of coronavirus responsible for the catastrophic second wave of corona in India, but when both doses of the vaccine are taken. A research claims that just one dose is not enough to reduce the effect of the B.1.617.2 variant of corona. Both doses of the vaccine are required to reduce the effect of this variant.
According to experts, India should now focus on expanding and accelerating vaccination campaign coverage and reconsider its decision to extend the time between two doses. Uk data was first reported by the Financial Times on Saturday. This data shows that a dose of the vaccine has less effect on the new variant of corona. The report also stated that a single dose of the vaccine provides 33 per cent protection from symtomatic infection symtomatic infection slated for B.1.617.2 variants. While B.1.1.7 provides 51 per cent protection from the variant.
According to the data, when people applied both doses of the vaccine, the difference in protection from infection decreased to 6 per cent. The data is based on a joint analysis of individuals taking pfizer-biotech and Oxford-Astrazeneca vaccine in the UK. Research has revealed that when individuals were given both doses of the vaccine, the symtomatic infection from the B.1.617.2 variant yielded 81 per cent protection, while the B.1.1.7 variant provided 87 per cent protection.
Also Read
'Nasal vaccine' will be 'game changer' in protecting children from corona: WHO Scientists
PM Modi will hold high level meeting today on cyclone 'Yaas'
Bihar: JDU leader's offensive act in home isolation, video call clip goes viral